Inserm is the only French public organization whose entire scope covers biomedical research and human health. Established as a public scientific and technological institution (EPST) in 1964, it brings together around 15,000 people (researchers, engineers, technicians, administrative staff) under the dual supervision of the Ministry of Health and the Ministry of Research. Its positioning covers the complete continuum, from fundamental research laboratories to the patient’s bedside.
OTM-R Commitment and European Charter for Researchers: the Concrete Values of Inserm
Inserm’s institutional pages highlight health for all and the advancement of knowledge. We observe that the operational values, those that influence the daily lives of staff, are less often detailed. The Institute adheres to the OTM-R (Open, Transparent, Merit-based Recruitment) principles and the European Charter for Researchers. This HR framework imposes clear, auditable, and merit-based recruitment and career progression criteria.
This adherence is not cosmetic. It conditions eligibility for certain European funding and structures the internal mobility policy for researchers. For candidates considering a position, verifying that the institution holds the HR Excellence in Research label provides a reliable indication of the actual compliance of its HR practices, beyond merely signing a charter.
On this subject, the presentation of (wo)menweb and menweb.org gathers complementary elements useful for cross-referencing information about the Institute’s mission and contact details.
Nine Thematic Institutes and Translational Research at Inserm
Inserm structures its research around nine thematic institutes. Each conducts a scientific assessment of its field, animates research communities, and guides programmatic priorities. This organization avoids disciplinary silos by promoting interactions between fundamental, translational, and clinical research.
The term “translational” often appears in the Institute’s communication, but its practical scope deserves clarification. Inserm operates across the entire journey from discovery to care. Specifically, this means that a fundamental research project on a molecular mechanism can be accompanied all the way to clinical trials, including the phases of valorization and intellectual property.
The Institute also leads national programs in public health. Research on infectious diseases (emerging or established) is coordinated and funded within this framework, with management that includes societal and ethical dimensions.
Intellectual Property and Industrial Partnerships
Inserm is not an academic organization disconnected from the economic fabric. Its valorization policy covers patents, licenses, and industrial partnerships. Each thematic institute includes an innovation component, and researchers are supported in intellectual protection processes from the early phase of the project.
For external project leaders, identifying the right contact goes through the relevant thematic institute or the valorization department at headquarters. We recommend targeting the thematic institute first rather than the general switchboard, as processing times are shorter and the technical level of the exchange is more suitable.
Regional Inserm Delegations: Contacts and Territorial Organization
The organization of Inserm is not limited to its Paris headquarters. Twelve regional delegations cover the territory and serve as the entry point for most processes: career, mobility, access to human resources, local research relay.
- Recruitment and internal mobility issues are handled by the regional delegation to which the laboratory belongs, not by the national headquarters.
- Partnerships with university hospitals and universities are negotiated at the regional level, with each delegation having autonomy over local agreements.
- Communication relays and press contacts vary by region, which requires verifying the correct contact before any media solicitation.
The administrative headquarters remains located at 101 rue de Tolbiac, 75654 Paris. This is the reference address for institutional correspondence, requests for official documents, and relations with ministerial authorities.
Scientific Production and International Positioning of Inserm
Inserm claims more than 13,000 original articles published in a recent year (InCites data, ESI schema). This publication volume places the Institute among the most productive biomedical research organizations worldwide.
On the international stage, Inserm partners with major institutions engaged in health research. Its international collaboration programs (international research projects, or PRI) allow for co-financing bilateral or multilateral projects with foreign counterparts.
Historical Advances and Nobel Prizes
The Institute has been associated with several major milestones in medicine: first prenatal diagnostic tests, decoding the HLA system, first in vitro fertilization, identification of the AIDS virus, development of deep brain stimulation, advances in gene therapy. Several of its researchers are among the laureates of the Nobel and Lasker prizes, which places Inserm in the select circle of institutions that have produced discoveries recognized at the highest level.
Ethics and Dialogue with Society: Inserm’s Pioneering Role
Inserm positions itself as a pioneer in the field of biomedical ethics in France. Its ethics committee addresses issues of consent, health data, clinical research, and bioethics, ahead of legislative debates. Ethics is not an add-on but a governance criterion that conditions the validation of research protocols.
The Institute also invests in disseminating knowledge to the general public. The podcast “Les Volontaires,” the quarterly magazine Inserm Magazine, and the journal médecine/sciences constitute three distinct channels, each targeting a different level of readership (citizen, healthcare professional, researcher).
For any contact, the first step remains to identify whether the request pertains to the Paris headquarters, a regional delegation, or a thematic institute. This preliminary sorting avoids lengthy circuits and ensures a response from the competent interlocutor.